دورية أكاديمية
Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia.
| العنوان: | Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia. |
|---|---|
| المؤلفون: | Amatngalim GD; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands G.D.Amatngalim@umcutrecht.nl.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Rodenburg LW; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Aalbers BL; Department of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands., Raeven HH; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Aarts EM; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Sarhane D; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Spelier S; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Lefferts JW; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Silva IA; BioISI-Biosystems and Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Lisboa, Portugal., Nijenhuis W; Department of Biology, Cell Biology, Neurobiology and Biophysics, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Centre for Living Technologies, Eindhoven-Wageningen-Utrecht Alliance, Utrecht, The Netherlands., Vrendenbarg S; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Kruisselbrink E; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Brunsveld JE; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Drunen CM; Department of Otorhinolaryngology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Michel S; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands., de Winter-de Groot KM; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands., Heijerman HG; Department of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands., Kapitein LC; Department of Biology, Cell Biology, Neurobiology and Biophysics, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Centre for Living Technologies, Eindhoven-Wageningen-Utrecht Alliance, Utrecht, The Netherlands., Amaral MD; BioISI-Biosystems and Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Lisboa, Portugal., van der Ent CK; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands., Beekman JM; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Member of ERN-LUNG, Utrecht, The Netherlands.; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Centre for Living Technologies, Eindhoven-Wageningen-Utrecht Alliance, Utrecht, The Netherlands. |
| المصدر: | Life science alliance [Life Sci Alliance] 2022 Aug 03; Vol. 5 (12). Date of Electronic Publication: 2022 Aug 03. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Life Science Alliance, LLC Country of Publication: United States NLM ID: 101728869 Publication Model: Electronic Cited Medium: Internet ISSN: 2575-1077 (Electronic) Linking ISSN: 25751077 NLM ISO Abbreviation: Life Sci Alliance Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Woodbury, NY] : Life Science Alliance, LLC, [2018]- |
| مواضيع طبية MeSH: | Cystic Fibrosis*/genetics, Cells, Cultured ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Epithelial Cells ; Humans ; Organoids |
| مستخلص: | Cystic fibrosis is caused by genetic defects that impair the CFTR channel in airway epithelial cells. These defects may be overcome by specific CFTR modulating drugs, for which the efficacy can be predicted in a personalized manner using 3D nasal-brushing-derived airway organoids in a forskolin-induced swelling assay. Despite of this, previously described CFTR function assays in 3D airway organoids were not fully optimal, because of inefficient organoid differentiation and limited scalability. In this report, we therefore describe an alternative method of culturing nasal-brushing-derived airway organoids, which are created from an equally differentiated airway epithelial monolayer of a 2D air-liquid interface culture. In addition, we have defined organoid culture conditions, with the growth factor/cytokine combination neuregulin-1<i>β</i> and interleukin-1<i>β</i>, which enabled consistent detection of CFTR modulator responses in nasal-airway organoid cultures from subjects with cystic fibrosis. (© 2022 Amatngalim et al.) |
| References: | J Cyst Fibros. 2004 Aug;3 Suppl 2:43-8. (PMID: 15463924) Nat Protoc. 2015 Oct;10(10):1474-85. (PMID: 26334867) Am J Respir Crit Care Med. 2021 May 15;203(10):1275-1289. (PMID: 33321047) Nat Protoc. 2019 Jun;14(6):1756-1771. (PMID: 31053799) Am J Respir Crit Care Med. 2018 Feb 15;197(4):481-491. (PMID: 29099608) Science. 1983 Sep 9;221(4615):1067-70. (PMID: 6308769) Eur Respir J. 2019 Jul 4;54(1):. (PMID: 31023844) Cell Rep. 2019 Feb 12;26(7):1701-1708.e3. (PMID: 30759382) Sci Transl Med. 2016 Jun 22;8(344):344ra84. (PMID: 27334259) J Vis Exp. 2017 Feb 11;(120):. (PMID: 28287550) Sci Rep. 2017 Aug 7;7(1):7375. (PMID: 28785019) EBioMedicine. 2014 Dec 17;2(2):147-53. (PMID: 26137539) J Cyst Fibros. 2018 Jan;17(1):26-33. (PMID: 28712885) Genes (Basel). 2020 May 29;11(6):. (PMID: 32485957) STAR Protoc. 2020 Jun 03;1(1):100019. (PMID: 33111074) Am J Physiol. 1992 Aug;263(2 Pt 1):C348-56. (PMID: 1514583) FASEB Bioadv. 2020 Aug 07;2(9):526-537. (PMID: 32923987) Lancet Respir Med. 2013 Apr;1(2):158-63. (PMID: 24429096) Science. 1989 Sep 8;245(4922):1066-73. (PMID: 2475911) Eur Respir J. 2021 Jan 5;57(1):. (PMID: 32747394) N Engl J Med. 2018 Oct 25;379(17):1612-1620. (PMID: 30334692) Genome Biol. 2002 Jun 18;3(7):RESEARCH0034. (PMID: 12184808) Am J Physiol Lung Cell Mol Physiol. 2021 Jul 1;321(1):L119-L129. (PMID: 34009038) Nat Biotechnol. 2019 Mar;37(3):303-313. (PMID: 30833775) J Cyst Fibros. 2019 Jan;18(1):22-34. (PMID: 29934203) Front Pharmacol. 2018 Oct 01;9:1112. (PMID: 30327603) Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L175-80. (PMID: 16489114) EMBO J. 2019 Feb 15;38(4):. (PMID: 30643021) Eur Respir J. 2022 Jan 27;:. (PMID: 35086832) Am J Respir Cell Mol Biol. 2010 Apr;42(4):472-81. (PMID: 19556605) Am J Respir Cell Mol Biol. 2017 May;56(5):568-574. (PMID: 27983869) Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L320-30. (PMID: 14527933) Eur Respir J. 2021 Dec 2;58(6):. (PMID: 34413153) Nat Med. 2021 May;27(5):806-814. (PMID: 33958799) Nat Med. 2013 Jul;19(7):939-45. (PMID: 23727931) Eur Respir J. 2018 Dec 20;52(6):. (PMID: 30287473) Med Sci (Basel). 2021 Feb 09;9(1):. (PMID: 33572202) J Biol Chem. 2001 Mar 23;276(12):9486-91. (PMID: 11114294) Nature. 2018 Aug;560(7718):377-381. (PMID: 30069046) Exp Lung Res. 2014 Sep;40(7):327-32. (PMID: 25058379) N Engl J Med. 2015 Jan 22;372(4):351-62. (PMID: 25607428) J Clin Invest. 2019 Oct 1;129(10):4433-4450. (PMID: 31524632) JCI Insight. 2017 Nov 16;2(22):. (PMID: 29202459) Nature. 2018 Aug;560(7718):319-324. (PMID: 30069044) |
| معلومات مُعتمدة: | 819219 International ERC_ European Research Council |
| المشرفين على المادة: | 126880-72-6 (Cystic Fibrosis Transmembrane Conductance Regulator) |
| تواريخ الأحداث: | Date Created: 20220803 Date Completed: 20220805 Latest Revision: 20240409 |
| رمز التحديث: | 20240409 |
| مُعرف محوري في PubMed: | PMC9351388 |
| DOI: | 10.26508/lsa.202101320 |
| PMID: | 35922154 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2575-1077 |
|---|---|
| DOI: | 10.26508/lsa.202101320 |